Skip to main content
. 2020 Oct 21;53(12):e9174. doi: 10.1590/1414-431X20209174

Table 3. Factors affecting recurrence-free survival by Cox's proportional hazards regression model analyses.

Items Univariate Cox's regression Multivariate Cox's regression
P value HR (95%CI) P value HR (95%CI)
lnc-MALAT1 (high vs low) 0.062 0.402 (0.154–1.047) 0.200 0.482 (0.157–1.473)
Age (≥61 vs <61 years) 0.976 0.986 (0.406–2.397) 0.974 0.981 (0.307–3.137)
Gender (male/female) 0.853 1.095 (0.421–2.850) 0.965 0.974 (0.304–3.120)
BMI (≥24.2 vs <24.2 kg/m2) 0.506 0.741 (0.307–1.791) 0.725 0.835 (0.305–2.282)
Smoking (yes vs no) 0.456 0.712 (0.291–1.741) 0.509 0.726 (0.281–1.876)
Hypertension (yes vs no) 0.836 1.167 (0.270–5.047) 0.704 1.371 (0.269–6.980)
Diabetes mellitus (yes vs no) 0.193 0.378 (0.088–1.633) 0.526 0.585 (0.111–3.075)
Hyperlipidemia (yes vs no) 0.853 0.920 (0.380–2.227) 0.978 1.015 (0.365–2.821)
Hyperuricemia (yes vs no) 0.958 1.026 (0.394–2.673) 0.712 0.819 (0.283–2.370)
CKD (yes vs no) 0.821 1.136 (0.377–3.418) 0.609 1.435 (0.360–5.728)
NIHSS score (≥7 vs <7) 0.428 0.701 (0.292–1.687) 0.229 0.557 (0.215–1.445)
CRP (≥29.0 vs <29.0 mg/L) 0.006 4.683 (1.563–14.028) 0.024 4.720 (1.224–18.197)
TNF-α (≥60.1 vs <60.1 pg/mL) 0.126 2.052 (0.818–5.151) 0.350 1.879 (0.501–7.041)
IL-6 (≥44.7 vs <44.7 pg/mL) 0.301 1.605 (0.655–3.931) 0.899 1.069 (0.381–2.996)
IL-8 (≥50.4 vs <50.4 pg/mL) 0.988 0.993 (0.413–2.387) 0.387 0.559 (0.149–2.088)
IL-10 (≥20.9 vs <20.9 pg/mL) 0.133 0.493 (0.196–1.239) 0.548 0.707 (0.227–2.195)
IL-17 (≥96.2 vs 96.2 pg/mL) 0.586 0.783 (0.324–1.889) 0.153 0.474 (0.170–1.319)
IL-22 (≥67.8 vs <67.8 pg/mL) 0.299 1.608 (0.656–3.942) 0.716 0.797 (0.235–2.705)

HR: hazard ratio; CI: confidence interval; BMI: body mass index; CKD: chronic kidney disease; NIHSS: National Institutes of Health Stroke Scale; CRP: C-reactive protein; TNF-α: tumor necrosis factor α; IL: interleukin. Significant P values are shown in bold.